The Innovative Medicines Initiative (IMI) is a Joint Undertaking (JU) between the European Union (EU), represented by the European Commission, and the European Federation of Pharmaceutical Industries and Associations (EFPIA). This partnership element between the EU and industry is essential to explaining how IMI is funded.